SCHEMBL3069368

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL3081399	0.86	BRD4 (0.39)	ARPTGDR2CACNA1HKLKB1
	SCHEMBL3077429	0.83	AR (0.50)	ARNSD2PTGDR2
	SCHEMBL3070012	0.83	AR (0.50)	ARNSD2PTGDR2
	SCHEMBL3081376	0.82	AR (0.49)	ARNSD2PTGDR2
	SCHEMBL3087297	0.81	AR (0.62)	ARNSD2
	SCHEMBL3063842	0.81	AR (0.48)	ARNSD2SLC22A12
	SCHEMBL3074078	0.81	AR (0.48)	ARNSD2
	SCHEMBL3081423	0.81	AR (0.48)	ARNSD2PTGDR2
	SCHEMBL3076734	0.81	AR (0.50)	ARNSD2PTGDR2
	SCHEMBL3081229	0.81	AR (0.50)	ARNSD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.